ACH-ATORVASTATIN CALCIUM 10 MG
ATORVASTATIN (ATORVASTATIN CALCIUM) : 10 MG · DIN 02457741 · ACCORD HEALTHCARE INC
Health Canada status: MARKETED
What is ACH-ATORVASTATIN CALCIUM?
ACH-ATORVASTATIN CALCIUM 10 MG contains ATORVASTATIN (ATORVASTATIN CALCIUM) : 10 MG. It is listed in the Health Canada Drug Product Database under DIN 02457741, held by ACCORD HEALTHCARE INC, supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 18-Oct-2019. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
What is ACH-ATORVASTATIN CALCIUM used for?
ACH-ATORVASTATIN CALCIUM is indicated in adults as an adjunct to lifestyle changes, including diet, for the reduction of elevated total cholesterol (total-C), LDL-C, triglycerides (TG), apolipoprotein B (apo B), the Total-C/HDL-C ratio and for increasing HDL-C in hyperlipidemic and dyslipidemic conditions, including Primary hypercholesterolemia (Type IIa), Combined (mixed) hyperlipidemia (Type IIb), Dysbetalipoproteinemia (Type III), Hypertriglyceridemia (Type IV), and Familial hypercholesterolemia (homozygous and heterozygous). It is also indicated for the prevention of Cardiovascular Disease, to reduce the risk of myocardial infarction in hypertensive patients without clinically evident coronary heart disease but with additional risk factors, in patients with type 2 diabetes mellitus and hypertension without clinically evident coronary heart disease but with other risk factors, and in patients with clinically evident coronary heart disease. In pediatrics (10 to <18 years of age), it is indicated as an adjunct to diet to reduce total-C, LDL-C, and apo B levels in boys and postmenarchal girls with heterozygous familial hypercholesterolemia, if after an adequate trial of diet therapy LDL-C remains ≥4.9 mmol/L (190 mg/dL) or LDL-C remains ≥4.1 mmol/L (160 mg/dL) and there is a positive family history of premature cardiovascular disease or two or more other CVD risk factors are present.
Authorized indication as written in the Health Canada product monograph. For healthcare professionals and licensed purchasers; this is not medical advice.
Product details and regulatory record
| DIN | 02457741 |
|---|---|
| Brand name | ACH-ATORVASTATIN CALCIUM |
| Generic / active ingredient | ATORVASTATIN (ATORVASTATIN CALCIUM) : 10 MG |
| Manufacturer | ACCORD HEALTHCARE INC |
| Strength | 10 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | C10AA05 ATORVASTATIN |
| AHFS class | 24:06.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 18-Oct-2019 |
| Original market date | 2019-10-18 00:00:00 |
How is it stored and handled?
null
How is it supplied?
10 mg: bottles of 90, 100, 500 tablets and blister of 30 tablets (3 strips x 10). 20 mg: bottles of 90, 100, 500 tablets and blister of 30 tablets (3 strips x 10). 40 mg: bottles of 90, 100, 500 tablets and blister of 30 tablets (3 strips x 10). 80 mg: bottles of 90, 100, 500 tablets and blister of 30 tablets (3 strips x 10).
Is ATORVASTATIN in shortage in Canada?
A Canadian shortage report is on file for this molecule: Anticipated — reported by SANIS HEALTH INC, last seen 04 Sep 2026. A shortage on one presentation does not always affect every DIN of the molecule — the alternatives below list what else is marketed in Canada. Nexara can confirm current availability and identify substitutions or import options where permitted.
What can be used instead?
Other Canadian products sharing ATC code C10AA05 ATORVASTATIN. 87 of 216 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ACH-ATORVASTATIN CALCIUM | 20 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02457768 |
| ACH-ATORVASTATIN CALCIUM | 40 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02457776 |
| ACH-ATORVASTATIN CALCIUM | 80 MG | TABLET | ACCORD HEALTHCARE INC | MARKETED | DIN 02457784 |
| APO-ATORVASTATIN | 10 MG | TABLET | APOTEX INC | MARKETED | DIN 02295261 |
| APO-ATORVASTATIN | 20 MG | TABLET | APOTEX INC | MARKETED | DIN 02295288 |
| APO-ATORVASTATIN | 40 MG | TABLET | APOTEX INC | MARKETED | DIN 02295296 |
| APO-ATORVASTATIN | 80 MG | TABLET | APOTEX INC | MARKETED | DIN 02295318 |
| ATORVASTATIN | 10 MG | TABLET | PRO DOC LIMITEE | MARKETED | DIN 02346486 |
| ATORVASTATIN | 10 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02348705 |
| ATORVASTATIN | 10 MG | TABLET | ANGITA PHARMA INC. | MARKETED | DIN 02506076 |
Who else supplies ATORVASTATIN worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. ATORVASTATIN appears in 2136 registered pack listings across 12 markets, published on 10 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.